Marco Adorni

Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

Lara Paracchini, Luca Beltrame, Tommaso Grassi et al. · Clinical Cancer Research · 2020 · 55 citations · Full text

Medicine, Molecular Genetics, Cancer Genetics +16

Detection of <i>TP53</i> Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis

Lara Paracchini, Chiara Pesenti, Martina Delle Marchette et al. · JAMA Network Open · 2020 · 24 citations · Full text

Medicine, Oncology, Pathology +15

Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers

Paolo Di Lorenzo, Vincenza Conteduca, Emanuela Scarpi et al. · Frontiers in Oncology · 2022 · 24 citations · Full text

Medicine, Oncology, Surgery +17

Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high‐grade serous ovarian cancer

Giuseppe Benvenuto, Paola Todeschini, Lara Paracchini et al. · International Journal of Cancer · 2020 · 20 citations · Full text

Medicine, Bioinformatics, Oncology +17

The impact of low-volume metastasis on disease-free survival of women with early-stage cervical cancer

Alessandro Buda, Jvan Casarin, Michael D. Mueller et al. · Journal of Cancer Research and Clinical Oncology · 2020 · 12 citations · Full text

Medicine, Gynecology, Oncology +16